July 28, 2015

Ramot at Tel Aviv University Ltd. and Neurimmune Announce Sponsored Research Agreement for Alzheimer’s Disease Treatment

Novel anti-ApoE antibodies to be developed for Alzheimer's disease treatment under a research and options agreement that includes pre-negotiated licensing terms for all ApoE-based products.

Read full article